Hepatitis A/B vaccine completion among homeless adults with history of incarceration

Journal of Forensic Nursing

Volumn 8, Issue 1, 2012, Pages 13-22

  Nyamathi, Adeline M ^a   Marlow, Elizabeth ^b   Branson, Catherine ^a   Marfisee, Mary ^a   Nandy, Karabi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Forensic nursing; Former prisoners; Hepatitis B; Homeless; Men; Vaccine completion

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ADULT; AGE; ARTICLE; CASE MANAGEMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; HEPATITIS A; HEPATITIS B; HOMELESSNESS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NURSING; PATIENT COMPLIANCE; PRISONER; RANDOMIZED CONTROLLED TRIAL; SPOUSE; STATISTICS; UNITED STATES; VACCINATION;

ADULT; AGE FACTORS; ALCOHOL DRINKING; CASE MANAGEMENT; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HOMELESS PERSONS; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRISONERS; SPOUSES; VACCINATION; YOUNG ADULT;

EID: 84857601248     PISSN: 15563693     EISSN: 19393938     Source Type: Journal    
DOI: 10.1111/j.1939-3938.2011.01123.x     Document Type: Article

References (51)

1. Altice, F. L., Bruce, R., Walton, M., & Buitrago, M. I. (2005). Adherence to hepatitis B virus vaccination at syringe exchange sites. Journal of Urban Health, 82(1), 151-161.
2. Anglin, M. D., Longshore, D., Turner, S., McBride, D., Inciardi, J., & Prendergast, M. (1996). Studies of the functioning and effectiveness of treatment alternatives to street crime (TASC) programs. Los Angeles : UCLA Drug Abuse Research Center.
3. Badiaga, S., Raoult, D., & Brouqui, P. (2008). Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerging Infectious Diseases, 14(9), 1353-1359.
4. Braithwaite, R. L., & Arriola, K. R. J. (2003). Male prisoners and HIV prevention: A call for action ignored. American Journal of Public Health, 93(5), 759-763.
5. Centers for Disease Control and Prevention (CDC). (2009). Surveillance for acute viral hepatitis-United States, 2007. MMWR, 58(SS-3), 1-27.
6. Christensen, P. B., Fisker, N., Krarup, H. B., Liebert, E., Jaroslavtsev, N., Christensen, K., & Georgsen, J. (2004). Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine, 22, 3897-3901.
7. Devasia, R. A., Jones, T., Kainer, M. Halford, S., Sheeler, L. L., Swift, J., & Schaffner, W. (2006). Two community hepatitis B outbreaks: an argument for vaccinating incarcerated persons. Vaccine, 24(9), 1354-1358.
8. Ewing, J. A. (1984). Detecting alcoholism: The CAGE questionnaire. JAMA, 252, 1905-1907.
9. Ford, W. L. (1992). Risk assessment for IV drug users not in treatment (Unpublished Instrument). AIDS Epidemiology Program, Dept. of Health Services, Los Angeles, California.
10. Freudenberg, N., Daniels, J., Crum, M., Perkins, T., & Richie, B. E. (2005). Coming home from jail: The social and health consequences of community reentry for women, male adolescents, and their families and communities. American Journal of Public Health, 95, 1725-1736.
11. Greenberg, G., & Rosenheck, A. (2008). Jail incarceration, homelessness, and mental health: A national study. Psychiatric Services, 59(2), 170-177.
12. Gunn, R. A., Lee, M. A., Murray, P. J., Gilchick, R. A., & Margolis, S. (2007). Hepatitis B vaccination of men who have sex with men attending an urban STD clinic: Impact of an ongoing vaccination program, 1998-2003. Sexually Transmitted Diseases, 54(9), 663-668.
13. Gupta, S., & Altice, F. L. (2009). Hepatitis B virus infection in US correctional facilities: A review of diagnosis, management, and public health implications. Journal of Urban Health, 86, 263-279.
14. Hagedorn, H., Dieperink, E., Dingmann, D., Durfee, J., Ho, S., Isenhart, C., Willenbring, M. (2007). Integrating hepatitis prevention services into a substance use disorder clinic. Journal of Substance Abuse Treatment, 32, 391-398.
15. Hennessey, K. A., Kim, A. A., Griffin, V., Collins, N. T., Weinbaum, C. M., & Sabin, K. (2009). Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: A case for viral hepatitis prevention in jails in the United States. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 86(1), 93-105.
16. Hernandez, B., Hasson, N. K., & Cheung, R. (2009). Hepatitis C performance measure on hepatitis A and B vaccination: Missed opportunities The American Journal of Gastroenterology, 104, 1961-1967.
17. Hiller, M. L., Webster, J. M., Garrity, T. F., Leukefeld, C. G., Narevic, E., & Staton, M. (2005). Prisoners with substance abuse and mental health problems: Use of health and health services. The American Journal of Drug and Alcohol Abuse, 1, 1-20.
18. Hudson, A. L., Nyamathi, A., Bhattacharya, D., Marlow, E., Shoptaw, S., Marfisee, M., Leake, B. (2011). Impact of prison status on HIV-related risk behaviors. AIDS & Behavior, 15, 340-346.
19. Kushel, M. B., Hahn, J. A., Evans, J. L., Bangsberg, D. R., & Moss, A. R. (2005). Revolving doors: Imprisonment among the homeless and marginally housed population. American Journal of Public Health, 95, 1747-1752.
20. Kushel, M. B., Vittinghoff, E., & Haas, J. S. (2001). Factors associated with the health care utilization of homeless persons. JAMA, 285(2), 200-206.
21. Latimer, W. W., Moleko, A., Melnikov, A., Mitchell, M., Severtson, S. G., von Thomsen, S., & Graham, C. (2007). Prevalence and correlates of hepatitis A among adult drug users: The significance of incarceration and race/ethnicity. Vaccine, 25, 7125-7131.
22. Lugoboni, F., Quaglio, G., Civitelli, P., & Mezzelani, P. (2009). Bloodborne viral hepatitis infections among drug users: The role of vaccination. International Journal of Environmental Research & Public Health, 6, 400-413.
23. Lum, P. L., Ochoa, K. C., Hahn, J. A., Shafer, K. P., & Moss, A. R. (2003). Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: The UFO Study. American Journal of Public Health, 93(6), 919-923.
24. MacDonnell, K. E., Naar-King, S., Murphy, D., Parsons, J., & Harper, G. (2009). Predictors of medication adherence in high risk youth of color living with HIV. Journal of Pediatric Psychology, 1-9.
25. Massoglia, M. (2008). Incarceration as exposure: The prison, infectious disease, and other stress-related illnesses. Journal of Health & Social Science Behavior, 49, 56-71.
26. McNiel, D. E., Binder, R. L., & Robinson, J. D. (2005). Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse. Psychiatric Services, 56, 840-846.
27. Motta-Castro, A., Gomes, S. A., Yoshida, C., Miguel, J. C., Teles, S. A., & Martins, R. M. (2009). Compliance with and response to hepatitis B vaccination in remaining quilombo communities in Central Brazil. Cad Saude Publica, 25(4), 738-742.
28. Mumola, C. J., & Karberg, J. C. (2006). Drug use and dependence, state and federal prisoners, 2004. Bureau of Justice Statistics Special Report, pp. 1-12. Retrieved from
29. Narevic, E., Garrity, T. F., Schoenberg, N. E., Hiller, M. L., Webster, J. M., Leukefeld, C. G., & Staton Tindall, M. (2006). Factors predicting unmet health services needs among incarcerated substance users. Substance Use & Misuse, 41, 1077-1094.
30. Nelson, M., Deess, P., & Allen, C. (1999). The first month out: Post-incarceration experiences in New York City. New York : Vera Institute of Justice.
31. Nyamathi, A. (1989). Comprehensive health seeking and coping paradigm. Journal of Advanced Nursing, 14, 281-290.
32. Nyamathi, A., de Castro, V., McNeese-Smith, D., Nyamathi, K., Shoptaw, S., Marfisee, M., & Cohen, A. (2008). Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection. Journal of Addictive Diseases, 27(4), 27-33.
33. Nyamathi, A. M., Liu, Y., Marfisee, M., Shoptaw, S., Gregerson, P., Saab, S., Gelberg, L. (2009a). Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. Nursing Research, 58(1), 13-22.
34. Nyamathi, A. M., Sinha, K., Saab, S., Marfisee, M., Greengold, B., Leake, B. & Schaffner, W. (2009b). Feasibility of completing an accelerated vaccine series for homeless adults. Journal of Viral Hepatitis, 16, 666-673.
35. Nyamathi, A. M., Nandy, K., Greengold, B., Marfisee, M., Khalilifard, F., Cohen, A., & Leake, B. (2011). Effectiveness of intervention on improvement of drug use among methadone maintained adults. Journal of Addictive Diseases, 30, 6-16.
36. Ompad, D. C., Galea, S., Wu, Y., Fuller, C. M., Latka, M., Koblin, B., & Vlahov, D. (2004). Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease & Public Health, 7(4), 294-300.
37. Poulos, R., Ferson, M., Orr, K., Lucy, A., Botham, S., McCarthy, M., Polis, S. (2007). Risk factors and seroprevalence of markers for hepatitis A, B and C in persons subject to homelessness in inner Sydney. Australian & New Zealand Journal of Public Health, 31(3), 247-251.
38. Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
39. Ramasami, S., Abu-Rajab, K., Sarkar, P., & Baguley, S. (2009). Audit of hepatitis B vaccination of men who have sex with men attending Scottish genitourinary medicine clinics. International Journal of STD & AIDS, 20, 575-576.
40. Rew, L., Grady, M., Whittaker, T. A., & Bowman, K. (2008). Interaction of duration of homelessness and gender on adolescent sexual health indicators. Journal of Nursing Scholarship, 40(2), 109-115.
41. Ritchey, F. J., La Gory, M., Fitzpatrick, K. M., & Mullis, J. (1990). A comparison of homeless, community-wide, and selected distressed samples on the CES-Depression Scale. American Journal of Public Health, 80, 1384-1386.
42. Rubenstein, L. V., Calkins, D. R., Young, R. Y., Cleary, P., Fink, A., Kosecoff J., Brook, R. H. (1989). Improving patient function: A randomized trial of functional disability screening. Annals of Internal Medicine, 111, 836-842.
43. Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science & Medicine, 32, 705-714.
44. Simpson, D., & Chatham, L. (1995). TCU/DATAR forms manual. Ft. Worth, TX : Institute of Behavioral Research, Texas Christian University.
45. Sneller, V., Fishbein, D. B., Weinbaum, C., Lombard, A., Murray, P., McLaurin, J. A., ... Working Group on Vaccination of High-Risk Adolescents. (2008). Vaccinating adolescents in high-risk settings: Lessons learned from experiences with hepatitis B vaccine. Pediatrics, 121(Suppl 1), S55-S62.
46. Stewart, A. L., Hays, R. D., & Ware, JE, Jr. (1988). The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care, 26, 724-735.
47. Vahdani, P., Hosseini-Moghaddam, S., Family, A., & Moheb-Dezfouli, R. (2009). Prevalence of HBV, HCV, HIV, and syphilis among homeless subjects older than fifteen years in Tehran. Archives of Iranian Medicine, 12(5), 483-487.
48. Van Herck, K., Leuridan, E., & Van Damme, P. (2007). Schedules for hepatitis B vaccination of risk groups: Balancing immunogenicity and compliance. Sexually Transmitted Infections, 83, 426-432.
49. Wolfers, M., de Wit, J., Hospers, H. J., Richardus, J. H., & de Zwart, O. (2009). Effects of a short individually tailored counseling session for HIV prevention in gay and bisexual men receiving hepatitis B vaccination. BMC Public Health, 9, 1-11.
50. Wouters, K., Leuridan, E., Van Herck, K., Van Ardenne, N., Roelofs, I., Mak, R., Van Damme, P. (2007). Compliance and immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium. Vaccine, 25, 1893-1900.
51. Zanis, D. A., Coviello, D. M., Lloyd, J. J., & Nazar, B. L. (2009). Predictors of drug treatment completion among parole violators. Journal of Psychoactive Drugs, 41(2), 173-180.